Drug Discovery Award

About this program

The Mark Foundation for Cancer Research’s Drug Discovery Award supports academic investigators advancing promising cancer targets into new therapeutic agents and preclinical development. Funding provides resources for post-target validation through early lead development, complemented by guidance from experienced biopharma R&D scientists. Applicants should be academic researchers with projects focused on discovering and progressing a novel cancer therapy along a defined path toward preclinical development.